Advanced Enzyme Tech enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


2,956	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
693	693	574	517	456
51.2	51.2	47.8	47.0	49.1
20.5	20.5	21.5	25.1	13.2
2,336	—	—	—	—
−672	−672	−553	−491	−443
₹208.68	—	—	—	—

1,704	1,704	1,490	1,396	1,297
1.2%	1.2%	1.4%	1.8%	1.0%
0.01×	—	—	—	—

3.12×	—	—	—	—
10.45×	—	—	—	—
12.75×	—	—	—	—
22.37×	—	—	—	—
750	746	637	624	541
224	229	194	204	156
183	189	158	169	121
—	157	142	141	140
104	104	108	99.0	102
—	104	107	98.2	102
—	52.4	34.8	42.4	38.2

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ADVENZYMES₹264.15

Advanced Enzyme Tech Ltd.

· Pharma & Health

₹ CrorePeersAARTIPHARM AARTIDRUGS AGARWALEYE AKUMS ALIVUS APLLTD CORONA HCGMcap ₹2,956 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	2,956.5
- Cash, Equiv & ST Investments	456.0	516.6	574.5	692.6	692.6
+ Minority Interest	49.1	47.0	47.8	51.2	51.2
+ Total Debt	13.2	25.1	21.5	20.5	20.5
Enterprise Value	—	—	—	—	2,335.6
Net Debt (memo)	-442.7	-491.5	-552.9	-672.1	-672.1
EV per Share	—	—	—	—	208.68

Total Capital	1,297.4	1,396.2	1,490.2	1,703.7	1,703.7
Total Debt/Total Capital	1.02	1.80	1.45	1.20	1.20
Total Debt/EV	—	—	—	—	0.01

EV/Sales	—	—	—	—	3.12
EV/EBITDA	—	—	—	—	10.45
EV/EBIT	—	—	—	—	12.75
EV/Free Cash Flow	—	—	—	—	22.37
Reference Items — Trailing FY Values
Sales	540.6	623.9	636.9	745.8	749.6
EBITDA	156.4	204.5	194.4	229.1	223.6
EBIT	121.4	169.2	157.9	189.0	183.2
Operating Cash Flow	140.4	141.4	142.5	156.8	—
Free Cash Flow	102.2	99.0	107.7	104.4	104.4
FCFF (free cash flow to the firm)	101.6	98.2	106.8	103.8	—
Capital Expenditure	38.2	42.4	34.8	52.4	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.